Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
There is considerable interest in the development of vaccination strategies that would elicit strong tumor-specific CTL responses in cancer patients. One strategy consists of using recombinant viruses encoding amino acid sequences corresponding to natural CTL-defined peptide from tumor Ags as immuno...
Główni autorzy: | Valmori, D, Lévy, F, Miconnet, I, Zajac, P, Spagnoli, G, Rimoldi, D, Liénard, D, Cerundolo, V, Cerottini, J, Romero, P |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
2000
|
Podobne zapisy
-
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
od: Valmori, D, i wsp.
Wydane: (2000) -
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
od: Pittet, M, i wsp.
Wydane: (1999) -
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
od: Valmori, D, i wsp.
Wydane: (1999) -
An antigen-targeted approach to adoptive transfer therapy of cancer.
od: Valmori, D, i wsp.
Wydane: (1999) -
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
od: Speiser, D, i wsp.
Wydane: (1999)